127 related articles for article (PubMed ID: 36737242)
1. Cofilin promotes vasculogenic mimicry by regulating the actin cytoskeleton in human breast cancer cells.
Nakajima M; Kawahara R; Simizu S
FEBS Lett; 2023 Apr; 597(8):1114-1124. PubMed ID: 36737242
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA 34a-AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells.
Lim D; Cho JG; Yun E; Lee A; Ryu HY; Lee YJ; Yoon S; Chang W; Lee MS; Kwon BS; Kim J
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374832
[TBL] [Abstract][Full Text] [Related]
4. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
[TBL] [Abstract][Full Text] [Related]
5. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
Hori A; Shimoda M; Naoi Y; Kagara N; Tanei T; Miyake T; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res; 2019 Aug; 21(1):88. PubMed ID: 31387614
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells.
Contreras-Sanzón E; Palma-Flores C; Flores-Pérez A; M Salinas-Vera Y; B Silva-Cázares M; A Marchat L; G Avila-Bonilla R; N Hernández de la Cruz O; E Álvarez-Sánchez M; Pérez-Plasencia C; D Campos-Parra A; López-Camarillo C
Cancer Biomark; 2022; 35(1):47-56. PubMed ID: 35662106
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
9. DPY19L3 promotes vasculogenic mimicry by its
Baydoun H; Kato Y; Kamo H; Hüsch A; Mizuta H; Kawahara R; Simizu S
Oncol Res; 2024; 32(4):607-614. PubMed ID: 38560568
[No Abstract] [Full Text] [Related]
10. The actin depolymerizing factor (ADF)/cofilin signaling pathway and DNA damage responses in cancer.
Chang CY; Leu JD; Lee YJ
Int J Mol Sci; 2015 Feb; 16(2):4095-120. PubMed ID: 25689427
[TBL] [Abstract][Full Text] [Related]
11. ErbB4-mediated regulation of vasculogenic mimicry capability in breast cancer cells.
Kawahara R; Simizu S
Cancer Sci; 2022 Mar; 113(3):950-959. PubMed ID: 34971015
[TBL] [Abstract][Full Text] [Related]
12. Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.
Cui YF; Liu AH; An DZ; Sun RB; Shi Y; Shi YX; Shi M; Zhang Q; Wang LL; Feng Q; Pan GL; Wang Q
Oncotarget; 2015 May; 6(13):11087-97. PubMed ID: 25871476
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
[TBL] [Abstract][Full Text] [Related]
14. Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer.
Collazo J; Zhu B; Larkin S; Martin SK; Pu H; Horbinski C; Koochekpour S; Kyprianou N
Cancer Res; 2014 Apr; 74(8):2362-73. PubMed ID: 24509905
[TBL] [Abstract][Full Text] [Related]
15. Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry.
Shimizu S; Kawahara R; Simizu S
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34913067
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231.
Liang W; Song S; Xu Y; Li H; Liu H
Mol Med Rep; 2018 May; 17(5):6711-6716. PubMed ID: 29512767
[TBL] [Abstract][Full Text] [Related]
17. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
[TBL] [Abstract][Full Text] [Related]
18. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M
Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
Tao W; Sun W; Zhu H; Zhang J
Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
[TBL] [Abstract][Full Text] [Related]
20. Cytochalasin D acts as an inhibitor of the actin-cofilin interaction.
Shoji K; Ohashi K; Sampei K; Oikawa M; Mizuno K
Biochem Biophys Res Commun; 2012 Jul; 424(1):52-7. PubMed ID: 22728040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
